Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adheron Therapeutics Inc.

Division of Roche
www.adherontherapeutics.com

Latest From Adheron Therapeutics Inc.

Finance Watch: A Bountiful November Harvest For Venture-Backed Biopharma

Five funds raised more than $1bn to back biotech firms; Arcus leads recent VC rounds with $107m GV-backed Series C; Celgene, Valeant sell notes to retire debt; and Alnylam cashes in on investor goodwill.

Financing Business Strategies

Biopharma Quarterly Dealmaking Statistics, Q4 2015

Biopharma financing for Q4 totaled $13.1 billion, a 35% increase over Q3, and again was dominated by follow-on public offerings. M&A reached a record $201 billion, topped by Pfizer's $160 billion buy of Allergan. Sanofi's $4.2 billion diabetes collaboration with Hanmi led the alliances.

BioPharmaceutical Deals

Deals In Depth: October 2015

BMS replaced and signed a new deal with Five Prime Therapeutics in immuno-oncology; there was more consolidation in the pharma services industry with Walgreens' $17.2 billion acquisition of Rite Aid. Biopharma financing in October was down from the previous month to $2.1 billion; device fundraising also decreased, to $468 million.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, November 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced October 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Synovex Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Roche
  • Senior Management
  • Hari Kumar, PhD, CEO
  • Contact Info
  • Adheron Therapeutics Inc.
    2930 Domingo Ave.
    P.O. Box 104 Berkeley, CA 94705
    USA
UsernamePublicRestriction

Register